Dong Wha Pharm Co., Ltd.(KR:000020)
₩5,370.000.00 (0.00%)
KR:000020
Dong Wha Pharm Co., Ltd. financials statements
₩5,370.00
At close:0.00 (0.00%)
Want to see KR:000020 full AI Analyst Report?
Dong Wha Pharm Co., Ltd. (000020) Income Statement
Dong Wha Pharm Co., Ltd. Income Statement
Last quarter (Q2 2026), Dong Wha Pharm Co., Ltd.'s total revenue was ₩136.93B, an increase of 9.52% from the same quarter last year. In Q2, Dong Wha Pharm Co., Ltd.'s net income was ₩6.65B. See Dong Wha Pharm Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ₩ 496.39B | ₩ 464.87B | ₩ 361.11B | ₩ 340.43B | ₩ 293.02B | |
| ₩ 203.33B | ₩ 214.26B | ₩ 190.42B | ₩ 180.99B | ₩ 149.35B | |
| ₩ 204.14B | ₩ 200.85B | ₩ 165.11B | ₩ 151.08B | ₩ 126.85B | |
| Depreciation and Amortization | ₩ 21.97B | ₩ 19.67B | ₩ 13.90B | ₩ 12.51B | ₩ 12.09B |
| ₩ 21.16B | ₩ 28.72B | ₩ 48.74B | ₩ 38.23B | ₩ 39.41B | |
| ₩ -809.25M | ₩ 13.41B | ₩ 25.30B | ₩ 29.92B | ₩ 22.50B | |
| ₩ 6.81B | ₩ -6.51B | ₩ 11.65B | ₩ -6.83B | ₩ 4.03B | |
| ₩ 6.00B | ₩ 6.90B | ₩ 36.96B | ₩ 23.09B | ₩ 26.53B | |
| ₩ 8.69B | ₩ 5.56B | ₩ 27.44B | ₩ 20.38B | ₩ 17.87B | |
| Per Share Metrics | |||||
| Basic EPS | ₩ 313.37 | ₩ 200.71 | ₩ 991.07 | ₩ 736.42 | ₩ 646.68 |
| Diluted EPS | ₩ 313.37 | ₩ 200.71 | ₩ 991.07 | ₩ 736.42 | ₩ 646.68 |
| Weighted Average Shares Outstanding | 27.93M | 27.72M | 27.69M | 27.68M | 27.63M |
| Weighted Average Shares Outstanding (Diluted) | 27.93M | 27.72M | 27.69M | 27.68M | 27.63M |
Currency in KRW

